PubMed COVID-19 Clinical Care
7491 - 7500 of 57555 results found
Acid-base balance and long COVID: comments on metabolic-respiratory alterations
Description
Long COVID is a multi-organ pathology with important sequelae that affect the health and welfare of survivors from the cellular bioenergetics, in this case, the importance of considering the acid-base balance within the processes of evaluation and
Detection of SARS-CoV-2 BA.2.86 by lateral flow devices
Description
We evaluated the performance of 12 lateral flow devices (LFDs) by assessing their analytical sensitivity for SARS-Cov-2 variant BA.2.86. Kits from ACON, Orient Gene, Xiamen Biotime, Getein and SureScreen detected variant BA.2.86 to sufficient
Clinical characteristics of SARS-CoV-2 Omicron variant infection in children with acute leukemia
Description
Hematologic diseases and various therapeutic stages can impact the presentation of SARS-CoV-2 Omicron variant infection. This study retrospectively analyzed data on Omicron infection in children with acute leukemia treated at our hospital between
Development and validation of the food quality score in ELSA-Brasil
Description
CONCLUSION: the FQS showed a satisfactory validity and reliability and was associated with socioeconomic and lifestyle data. Therefore, it is a useful tool for comparing dietary information, thus contributing to nutritional epidemiology.
Efficacy and safety of intravenous fosphenytoin for patients with acute herpes zoster-associated pain: A placebo-controlled randomized trial
Description
Acute zoster-associated pain develops in most patients with herpes zoster. Nonopioid analgesics are usually used to treat acute zoster-associated pain but are frequently ineffective. We administered intravenous fosphenytoin, the prodrug of phenytoin
Immunoinformatics lessons on the current COVID-19 pandemic and future coronavirus zoonoses
Description
No abstract
Clinical development of antivirals against SARS-CoV-2 and its variants
Description
The unceasing global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) calls for the development of novel therapeutics. Although many newly developed antivirals and repurposed antivirals have been applied to the treatment of
Gut microbiota composition is associated with disease severity and host immune responses in COVID-19
Description
CONCLUSION: These results suggested that the gut microbiome could have a potential function in regulating host immune responses and impacting the severity or consequences of diseases.
Comparison of Azvudine and Nirmatrelvir/Ritonavir and Combined Use in Patients with COVID-19
Description
CONCLUSION: Azvudine is recommended for patients with non-severe COVID-19 with weakness. Nirmatrelvir/ritonavir is recommended for patients with severe COVID-19, to reduce mortality, and it could be the best choice for patients with hepatic
